AI-Enhanced Standalone Endoscopic Objective Image Analysis System

Publication ID: 24-11857151_0005_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “AI-Enhanced Standalone Endoscopic Objective Image Analysis System,” Published Technical Disclosure No. 24-11857151_0005_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857151_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,151.

Summary of the Inventive Concept

A next-generation standalone endoscopic objective image analysis system that leverages AI-driven image processing, real-time anomaly detection, and cloud-based deep learning models to provide comprehensive, 3D-reconstructed images of target areas and objective performance metrics.

Background and Problem Solved

The original patent, 'Systems and methods for standalone endoscopic objective image analysis', addressed the need for evaluating the performance of an endoscope's objective. However, this approach has limitations, including the need for manual evaluation and the lack of real-time feedback. The new inventive concept addresses these limitations by introducing AI-driven image processing, real-time anomaly detection, and cloud-based deep learning models to provide a more efficient, accurate, and comprehensive evaluation of endoscope objectives.

Detailed Description of the Inventive Concept

The AI-enhanced standalone endoscopic objective image analysis system comprises a modular, AI-driven image processing module that receives and analyzes a plurality of intermediate images captured from a standalone objective. The module generates a comprehensive, 3D-reconstructed image of the target area and provides objective performance metrics. The system also integrates a real-time, machine learning-based anomaly detection algorithm, enabling real-time alerts and notifications for objective-related issues. The system can be cloud-based, allowing for remote access and collaboration. The AI-driven image processing module utilizes a deep learning model trained on a large dataset of endoscope objectives to generate the comprehensive, 3D-reconstructed image and objective performance metrics.

Novelty and Inventive Step

The new inventive concept introduces AI-driven image processing, real-time anomaly detection, and cloud-based deep learning models, which are not present in the original patent. These features enable a more efficient, accurate, and comprehensive evaluation of endoscope objectives, providing a significant improvement over the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include integrating the AI-driven image processing module with other medical devices, such as microscopes or surgical robots, to provide real-time image analysis and feedback. Another variation could be the use of edge computing or fog computing to enable real-time processing and analysis of images at the point of care.

Potential Commercial Applications and Market

The AI-enhanced standalone endoscopic objective image analysis system has significant commercial potential in the medical device industry, particularly in the areas of endoscopy, microscopy, and surgical robotics. The system could be marketed as a standalone device or integrated into existing medical devices, providing a competitive advantage to manufacturers and improving patient outcomes.

CPC Classifications

SectionClassGroup
A A61 A61B1/00009
A A61 A61B1/04
G G06 G06T5/003
G G06 G06T5/006
G G06 G06T7/0012
H H04 H04N23/67
G G06 G06T5/005
G G06 G06T7/174
G G06 G06T2207/10068
G G06 G06T2207/20221
G G06 G06T2207/30168
H H04 H04N23/6845
H H04 H04N23/951

Original Patent Information

Patent NumberUS 11,857,151
TitleSystems and methods for standalone endoscopic objective image analysis
Assignee(s)STERIS Instrument Management Services, Inc.